to the kallikrein panel resulted in a nonsignificant increase in AUC in the academic centers cohort (0.012, 95% CI -0.032, 0.055).
INTRODUCTION AND OBJECTIVES:
Prostate cancer is the second most diagnosed male cancer, with a growing prevalence at autopsies (59% at ages greater than 79 years). The risk of developing clinical disease is 10-20%, so biopsy may be considered in elderly patients. The objective is to evaluate the outcome of patients with more than 75 years who underwent prostate biopsy at our institution.
METHODS: The records were retrospectively evaluated from January 2010 to December 2017. Two groups were created: patients whose age at biopsy was between 75 and 79 years [group 1 -seniors (S)] and equal or more than 80 years [group 2 e super seniors (SS)]. The SPSS Statistics 23.0 software was used and p value <0.05 was accepted as statistically significant. RESULTS: Of 2700 biopsies, 363 (13.4%) were included. S group included 232 (63.9%) and SS group included 131 (36.1%), with only 29 (8%) being older than 85 years.
The majority of S patients had initial PSA less than 10 ng/mL (54.5%; median PSA: 9.2 AE 226.2 ng/mL) and the majority of SS patients had PSA greater than 20 ng/mL (43.3%; median PSA: 16.52AE87.0 ng/ml) p <0.001.
Pathology revealed more advanced histology in SS group, including higher ISUPs [ISUP 4-5 in SS (13.8% vs 31.3%) and ISUP 2 (38.4% versus 32.1%) and ISUP 1 (27.6% versus 16.8%) in S group, p<0.001], higher incidence of bilateral disease (51.7% vs 67.9%, p[ 0.003), vascular (7.8% vs 19.1%, p[0.003) and lymphatic invasion (6.5% vs 13.0%, p[ 0.05).
The initial treatment performed was: classic hormonotherapy (69.8% vs 92.4%), radical radiotherapy (17.7% vs 0.8%), watchful waiting (6.9 vs 6.1%), radical prostatectomy (4.3% vs 0%) and brachytherapy (1.3% vs. 0.8%), p <0.001. Only 6.6% (n[24) had metastasis at beginning.
The last mean PSA was 36.5AE143. In univariate analysis, there was a statistically significant association between death and: initial PSA, several pathological variables, initial treatment, metastasis, hospitalizations and emergency department consultations, p <0.05. However, in the multivariate analysis, only age at biopsy showed a statistically significant association with death (p [ 0.03).
CONCLUSIONS: Prostate biopsy was performed in the super seniors groups, mainly when the initial PSA was higher. These patients had a more aggressive histology with a higher incidence of bilateral and lymphovascular invasion. However, the only factor that limited survival was the age at biopsy.
Source of Funding: None

MP18-18 COMPLICATIONS AFTER RANDOM TRUS GUIDED TRANSRECTAL PROSTATE BIOPSY
Giorgio Napodano, Tommaso Realfonso, Raffaele Baio, Giovanni Molisso, Maria Addesso, Roberto Sanseverino*, Nocera Inferiore, Italy INTRODUCTION AND OBJECTIVES: Prostate biospy is the gold standard procedure to diagnose prostate cancer. The technique is usually performed under transrectal ultrasound (TRUS) guidance with transrectal or transperineal approach. Every year more than 1 milion pof procedure are realized in Europe. Complication rate is quite low; however fearsome infectious complications are increasing. We have retrospectively evaluated complication rate in our database and we have analyzed predictive factor of complications METHODS: From database of our institution we have evaluated complications of patients undergone transrectal random prostate biopsy for suspicion of prostate cancer. Complications were classified as bleeding more than 3 days after biopsy (hematuria, hematospermia, rectal bleeding), infection defined as fever more than 38 C, acute urinary retention (RUA). Hospitalization due to complication was ha salso been recorded. We have correlated every complication with age, prostate volume, PSA, PSAD, BMI, number of cores, cancer detection, diabetes mellitus, previous urinary or genital infection, BPCO, previous urological surgery, previous or concomitant tumor. Statistical analysis was performed using Chi square test, Mann Whitney, logistic regression test, as appropriate (SPSS 19) .
RESULTS: Data on 2.106 patients were collected. Patients characteristics are reported in table 1. Complications occurred in 6.4% of the patients (table 2) . Multivariate analysis revealed correlation only for infection with previous history of urinary or genital infection (p0.001, OR 0.012 -CI 0.001-0.162) (table 3). A minority of patients (15 out of 2.106 0.7%) required hospitalization because of complications (11 for infection, 2 for hematuria, 1 for rectal bleeding, 1 for AUR). However 11.2% (15 of 134) of patients with complicatons needed hospital admisison. Previous urinary or genital infection was the only factor associated with hospitalization (p0.001 -0.005 0.000-0.125).
CONCLUSIONS: Transrectal random prostate biopsy is a common and safe procedure. Complications rate is generally low (6.4%); hematospermia is more frequent complication (4.7%). Hospitalization is rarely needed (0.7%). However fearsome and lifethreatening infectious complications are main causes of hospital admission.
